1. Home
  2. PRE

as 12-18-2024 12:41pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

Founded: 2014 Country:
Hong Kong
Hong Kong
Employees: N/A City: N/A
Market Cap: 72.6M IPO Year: N/A
Target Price: $9.00 AVG Volume (30 days): 13.0K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.81 EPS Growth: N/A
52 Week Low/High: $2.85 - $7.84 Next Earning Date: 11-27-2024
Revenue: $25,561,362 Revenue Growth: -90.86%
Revenue Growth (this year): 64.44% Revenue Growth (next year): 154.24%

PRE Daily Stock ML Predictions

Share on Social Networks: